855475 | 12:0 Lyso PC
1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine

12:0 Lyso PC
1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine
CAS Registry Number is a Registered Trademark of the American Chemical Society
PC(12:0/0:0)
Wen SY, Chen YY, Lu JX, Liang QQ, Shi H, Wu Q, Yao ZH, Zhu Y, Jiang MM. Modulation of hepatic lipidome by rhodioloside in high-fat diet fed apolipoprotein E knockout mice. Phytomedicine. 2020 Apr;69:152690. doi: 10.1016/j.phymed.2018.09.225. Epub 2018 Sep 27. PMID: 30389273.
PubMed ID: 30389273Miaomiao Jiang, Jingyu Ni, Yuanlin Cao, Xiaoxue Xing, Qian Wu, and Guanwei Fan, “Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury from Oxidative Stress by Regulating Succinate, Lysophospholipid Metabolism, and ROS Scavenging System,” Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 9137654, 17 pages, 2019. doi: 10.1155/2019/9137654.
Quan H, Bae HB, Hur YH, Lee KH, Lee CH, Jang EA, Jeong S. Stearoyl lysophosphatidylcholine inhibits LPS-induced extracellular release of HMGB1 through the G2A/calcium/CaMKKβ/AMPK pathway. Eur J Pharmacol. 2019 Feb 21;852:125-133. doi: 10.1016/j.ejphar.2019.02.038. [Epub ahead of print]
PubMed ID: 30797785Pedersen JN, Jiang Z, Christiansen G, Lee JC, Pedersen JS, Otzen DE. Lysophospholipids induce fibrillation of the repeat domain of Pmel17 through intermediate core-shell structures. Biochim Biophys Acta Proteins Proteom. 2018 Nov 22. pii: S1570-9639(18)30205-X. doi: 10.1016/j.bbapap.2018.11.007. [Epub ahead of print]
PubMed ID: 30471451Stafford, R.E., Fanni, T., Dennis, E.A. (1989) Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry. 28(12):5113-20.
PubMed ID: 2669968Stafford RE, Fanni T, Dennis EA. Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry. 1989 Jun 13;28(12):5113-20.
PubMed ID: 2669968- Certificate of Analysis (Lot No. 855475C-25MG-A-044 and 5773CJA044)
- Certificate of Analysis (Lot No. 855475P-200MG-A-044 and 5773PNA044)
- Certificate of Analysis (Lot No. 855475P-25MG-A-044 and 5773PJA044)
- Certificate of Analysis (Lot No. 855475P-500MG-A-044 and 5773PPA044)
- Certificate of Analysis (Lot No. 855475P-25MG-B-044 and 5773PJB044)
- Certificate of Analysis (Lot No. 855475P-500MG-B-044 and 5773PPB044)
- Certificate of Analysis (Lot No. 855475P-25MG-A-045 and 5773PJA045)
- Certificate of Analysis (Lot No. 855475P-200MG-A-045 and 5773PNA045)
- Certificate of Analysis (Lot No. 855475C-25MG-A-045 and 5773CJA045)
- Certificate of Analysis (Lot No. 855475P-200MG-A-046 and 5773PNA046)
- Certificate of Analysis (Lot No. 855475C-25MG-A-046 and 5773CJA046)
- Certificate of Analysis (Lot No. 855475P-25MG-A-046 and 5773PJA046)
- Certificate of Analysis (Lot No. 855475P-200MG-B-046 and 5773PNB046)
- Certificate of Analysis (Lot No. 855475P-200MG-A-048 and 5773PNA048)
- Certificate of Analysis (Lot No. 855475P-500MG-A-048 and 5773PPA048)
- Certificate of Analysis (Lot No. 855475P-200MG-B-048 and 5773PNB048)
- Certificate of Analysis (Lot No. 855475P-500MG-B-048 and 5773PPB048)
- Certificate of Analysis (Lot No. 855475P-500MG-C-048 and 5773PPC048)
- Certificate of Analysis (Lot No. 855475P-25MG-B-047 and 5773PJB047)